Q3 2015 13F Holders as of 30 Sep 2015
-
Type / Class
-
Equity / COMMON STOCK
-
Shares outstanding
-
95,963,102
-
Number of holders
-
156
-
Total 13F shares, excl. options
-
35,309,662
-
Shares change
-
+2,853,322
-
Total reported value, excl. options
-
$3,400,791,001
-
Value change
-
+$270,511,040
-
Put/Call ratio
-
163%
-
Number of buys
-
117
-
Number of sells
-
-51
-
Price
-
$96.31
Significant Holders of Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) as of Q3 2015
192 filings reported holding RARE - Ultragenyx Pharmaceutical Inc. - COMMON STOCK as of Q3 2015.
Ultragenyx Pharmaceutical Inc. - COMMON STOCK (RARE) has 156 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 35,309,662 shares
of 95,963,102 outstanding shares and own 37% of the company stock.
Largest 10 shareholders include FMR LLC (5,799,996 shares), Capital Research Global Investors (4,738,511 shares), VANGUARD GROUP INC (2,118,090 shares), WELLINGTON MANAGEMENT GROUP LLP (1,876,646 shares), WELLS FARGO & COMPANY/MN (1,554,990 shares), BlackRock Fund Advisors (1,483,381 shares), PRICE T ROWE ASSOCIATES INC /MD/ (1,358,955 shares), COLUMBIA WANGER ASSET MANAGEMENT LLC (1,252,614 shares), STATE STREET CORP (856,881 shares), and BlackRock Institutional Trust Company, N.A. (853,743 shares).
This table shows the top 156 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.